Senior Medical Science Liasion

Medical Manager

Purpose:

The MSL is a credible and valued representative of the company in field to interact with key stakeholders across their regions/products/TAs to establish and maintain scientific relationships with opinion leaders and other healthcare professionals via scientific approach that is aligned with the Brand Team objectives and therapeutic area Medical Plan.

The MSL is responsible for providing a variety of external and internal customers with medical and scientific information on the appropriate utilization of specific company products and with more general information about their therapeutic area and disease state.

The MSL attends conferences and meetings on behalf of the company as scientific expert with the objective of bringing back information on the latest scientific advances in a specific therapeutic area.

OR)

External stakeholder engagement

• The MSL is a credible and valued representative of the company in field to interact with key stakeholders across their regions/products/TAs to establish and maintain scientific relationships with opinion leaders and other healthcare professionals via scientific approach that is aligned with the Brand Team objectives and therapeutic area Medical Plan.
• MSLs will spend the majority of their time in field based and customer facing activities by engaging in mutually beneficial 2-way dialogues with scientific experts/key opinion leaders.
• The MSL is responsible for providing a variety of external and internal customers with medical and scientific information on the appropriate utilization of specific company products and with more general information about their therapeutic area and disease state.
• The MSL attends conferences and meetings on behalf of the company as scientific expert and is required to bring updates on the latest scientific advances in a specific therapeutic area back to the company brand team as well as external stakeholders.
• Engages with clinical and medical oncologists to share scientific data on DRL Oncology NCE/ NBE assets and share phase 3 clinical trial data. Discuss the clinical unmet need and current treatment landscape as well as global guidelines and pipeline molecules. The incumbent will be expected to spend 70% of time in-field engaging key opinion leaders. The incumbent will also develop an adoption ladder to measure the adoption of the NCE/ NBE by the clinicians.
• Lead the design and implementation of early access program if required. 
• Stay abreast of all clinical developments in specific therapeutic area and possible opportunity or challenge for the local business.
• Collaborate outside the company with stakeholders to achieve common goals of the company - building a long-term plan of activities with leading scientific organizations and communities.
• Coordinate planning of scientific publications in credible scientific journals.
• Perform key opinion leader mapping for relevant cancers and establish a scientific advisory board under the leadership and guidance of the COE medical teams which will assist DRL in launching innovative assets. Regularly engage advisory board members.
• Prepare speaker development program in collaboration with global COE medical affairs team.
• Create a plan for the companys collaboration with key opinion leaders.
• To implement and disseminate high quality medical and scientific education in the field to give clinical and scientific presentations at sites and to key external audience including local decision makers and budget holders in co-operation with COE medical teams local marketing and sales function.

Medico-Marketing

• Provide input in the strategic segmentation of customers together with COE medical teams and ensure MSL in-field material and discussion aligns with the segmentation of the key external expert.
• Contribute towards building patient and HCP decision journeys identify and prioritize leverage points from patient/ HCP journey.
• Contribute to the scientific elements of a detailed Brand plan for oncology NCE/ NBE assets.
• Prepare key clinical messages for oncology NCE/NBE assets from a scientific communication perspective.
• Collaborate with physicians on medical affairs initiatives including publications advisory boards medical education opportunities training and speaker development Similar phrase was put in section 13 but giving more specific and broaden details makes it more complete/comprehensive in my opinion.
• Conduct continuous medical education initiatives - webinars face to face and alternative digital channels.
• Find innovative ways to engage with customers and increase DRL scientific share of voice.
• Create specialized content for different target audiences. Have knowledge of how to extract customer insights.
• Identify barriers and create communication plan based on insights.
• Prepare a formal insight gathering and dissemination plan based on KOL and field insights.
• Develop an understanding of the regional landscape including specialties involved in care of patient.
• Communicate clinical insights on new data to the company Medical Affairs and to inform medical strategy for the therapeutic area.

Data Generation Plan

• Identify any data gaps and propose post-marketing studies to close the data gaps.
• Responsible for assisting in the preparation of study synopses study protocols case report forms.
• Prepare publications and congress abstracts in collaboration with key external experts.
• Support clinical development initiatives including site identification trial recruitment registry and presentation of final approved data.

Sales Force Engagement

• Conduct trainings with the sales team in collaboration with the COE medical teams.

Code of ethics and compliance

• Full adherence to Dr Reddys and Australia code of marketing and ethical engagements with Key Opinion Leaders
• Complete on-boarding training matrix within agreed time
• Maintain up to date training register and adherence to all company training requirements within allocated timelines.
• Adhere to all policies and processes relevant to specific role/ function including but not limited to LMRC promotional material management Contracting and procurement processes execution of events engagements with HCPs expense policies etc

Strategic Vision and Leadership

• MSLs synthesize complex data and effectively communicate meaningful clinical insights and unanswered customer questions they receive from opinion leaders to Dr Reddys medical and cross functional teams.
   

BU wide Transformation initiatives

• Take lead in proposing BU wide transformation initiatives which could create distinct value for the organization. Facilitate implementation review & tracking such initiatives (for e.g. safety productivity manufacturing excellence).

Depending on the business requirements and strategic direction for the BU identify specific areas / projects / problems; engage with business teams and external entities to work out solutions; partner in implementing the solutions; monitor the progress and help troubleshoot when needed IN ORDER TO create value for the BU through various initiatives.

Qualifications :

Qualification:

• PhD or Masters in pharmacy/ pharmacology or medical sciences
• At least 3 years experience in a Medical Science Liaison role within pharma
• Oncology experience is a pre-requisite.
• Excellent stakeholder engagement skills
• Experience in launching innovative assets.

Additional Information :

About the Department
Emerging Markets
Branded generics is one of our biggest businesses in Emerging market and our branded products are available 48 countries across 5 regions. Our key markets are Russia China and Brazil. We also have presence in Latin America Africa Australia New Zealand ASEAN (Association of Southeast Asian Nations) CIS and Romania. We have added 13 new geographies in the last 5 years.
In the last 4 years our emerging markets business growth rate has doubled (June 22). Our diverse portfolio spans all segments. We are continuously advancing technologies enhancing efficiency of operations and increasing our portfolio of highest-quality quality products.
With nearly 40 products and 6 mega brands Russia is a key market. With more than 30 years of operations in the region as of FY22 we have reported a year-on-year growth of 32%. This was driven by improved existing business performance launch of new products during the year along with divestment of some non-core brands. 6 key products were ranked among the top 200 bestselling formulation brands as per IQVIA in its report for the 12-month period ended 31 March 2022. 5 of our leading products were voted as the Product of the Year by the consumers reaffirming the trust that the people of Russia have in them.
We are among the earliest Indian pharma companies to have a business presence in China. We have a representative office that focuses on filings and approvals including the Group Purchasing Organisation (GPO). Our joint venture entity (Kunshan Rotam Reddy Pharmaceutical Co. Ltd) offers a portfolio of niche and essential products strengthening our presence in China.
In Latin America we have a strong presence in Brazil and just a little over five years in Brazil our team has established itself in the region with our diverse portfolio. Our primary focus in Brazil is oncology and institutional. Our team in Colombia was certified as a Great Place to Work.
Through our comprehensive COVID-19 portfolio we were able to reach over 5 million patients in low and middle-income countries. With the aim of reaching more and more patients around the world we are harnessing our deep science capabilities to create a robust portfolio in the region to become the partner of choice.
Our teams in China Brazil Colombia and Thailand Malaysia are a certified great place to work. Our team in Russia is among the top 3 in Head-hunters Best Employer Ranking in 2022. These recognitions reaffirm our commitment and efforts to bring science technology and innovation together to offer affordable medicines and solutions beyond the pill to patients in the region.
As the need scope and standards of healthcare evolve we keep track of emerging needs to contribute to patient welfare. After all Good Health Cant Wait

Benefits Offered
At Dr. Reddys we actively help to catalyse your career growth and professional development through personalised learning programs.
The benefits you will enjoy at Dr. Reddys are on par with the best industry standards. They include among other things and other essential equipment joining & relocation support family support (Maternity & Paternity benefits) learning and development opportunities medical coverage for yourself and your family life coverage for yourself.

Our Work Culture
Ask any employee at Dr. Reddys why they come to work every day and theyll say because Good Health Cant Wait. This is our credo as well as the guiding principle behind all our actions. We see healthcare solutions not only as scientific formulations but as a means to help patients lead healthier lives and were always attuned to the new and the next to empower people to stay fit. And to do this we foster a culture of empathy and dynamism. People are at the core of our journey over the last few decades. They have been supported by an enabling environment that buoys individual ability while fostering teamwork and shared success. We believe that when people with diverse skills are bound together by a common purpose and value system they can make magic.
For more details please visit our career website at Work :

No

Employment Type :

Full-time